BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 33760284)

  • 1. Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches.
    Jenks JD; Nam HH; Hoenigl M
    Mycoses; 2021 Sep; 64(9):1002-1014. PubMed ID: 33760284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
    Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
    Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
    Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
    Dupont D; Menotti J; Turc J; Miossec C; Wallet F; Richard JC; Argaud L; Paulus S; Wallon M; Ader F; Persat F
    Med Mycol; 2021 Jan; 59(1):110-114. PubMed ID: 32914189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillosis in Critically Ill Patients with and Without COVID-19 in a Tertiary Hospital in Southern Brazil.
    Trápaga MR; Poester VR; Basso RP; Blan BDS; Munhoz LS; Pasqualotto AC; Werner TDF; Figurelli ML; Stevens DA; von Groll A; Xavier MO
    Mycopathologia; 2024 Jun; 189(3):48. PubMed ID: 38847987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point of care aspergillus testing in intensive care patients.
    Mercier T; Dunbar A; Veldhuizen V; Holtappels M; Schauwvlieghe A; Maertens J; Rijnders B; Wauters J
    Crit Care; 2020 Nov; 24(1):642. PubMed ID: 33168049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
    Huang L; He H; Jin J; Zhan Q
    BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report.
    Schein F; Munoz-Pons H; Mahinc C; Grange R; Cathébras P; Flori P
    J Mycol Med; 2020 Dec; 30(4):101039. PubMed ID: 32861584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
    Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
    J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate.
    van Grootveld R; van Paassen J; de Boer MGJ; Claas ECJ; Kuijper EJ; van der Beek MT;
    Mycoses; 2021 Jun; 64(6):641-650. PubMed ID: 33606324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis.
    Bassetti M; Giacobbe DR; Grecchi C; Rebuffi C; Zuccaro V; Scudeller L;
    J Infect; 2020 Jul; 81(1):131-146. PubMed ID: 32330523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.
    Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I
    APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids.
    Sasoni N; Rodriguez Müller M; Posse G; González J; Leonardelli F; Garcia-Effron G
    Rev Iberoam Micol; 2021; 38(1):16-18. PubMed ID: 33500209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
    Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
    Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: implications for screening and treatment.
    Tio SY; Williams E; Worth LJ; Deane AM; Bond K; Slavin MA; Sasadeusz J
    Intern Med J; 2021 Dec; 51(12):2129-2132. PubMed ID: 34939293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
    Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
    J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients.
    Mikulska M; Furfaro E; Dettori S; Giacobbe DR; Magnasco L; Dentone C; Ball L; Russo C; Taramasso L; Vena A; Angelucci E; Pelosi P; Bassetti M
    Mycoses; 2022 Apr; 65(4):411-418. PubMed ID: 35138675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.